You are here

CP-690-550 Ointment For Chronic Plaque Psoriasis

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Mobile, Alabama, 36606 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Psoriasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Mild to moderate chronic plaque psoriasis (psoriasis vulgaris), with the duration of
at least 6 months;

- A target plaque of at least 9 sq. cm.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Demonstrates "rebound" or "flare" of chronic plaque psoriasis;

- Non plaque form of psoriasis;

- Currently have or history of psoriatic arthritis;

- Current drug induced psoriasis;

- Currently on systemic therapy or was on systemic therapy for psoriasis within the
previous 6 months;

- Currently on phototherapy for psoriasis or was on phototherapy within the previous 3
months

NCT01246583
Pfizer
Completed
CP-690-550 Ointment For Chronic Plaque Psoriasis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Psoriasis Vulgaris, Psoriasis Arthropathica, Pustular Psoriasis, Erythrodermic Psoriasis
NCT03885089
All Genders
0+
Years
Tokyo,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now